|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,697.50 INR | -1.01% |
|
+0.14% | -1.29% |
| 02-13 | Biocon aims for revenue surge with rollout of generic weight-loss drugs | RE |
| 02-02 | Nomura Adjusts Sun Pharmaceutical Industries' Price Target to INR1,920 From INR1,960, Keeps at Buy | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 0.86% | 0.96% | 35.27x | 5.11x | 6.69x | 22.96x | 27.89x | 45.42B | |
| 1.45% | 1.47% | 15.59x | 1.78x | 2x | 8.29x | 10.74x | 34.2B | |
| 1.03% | 1.05% | 25.64x | 3.12x | 3.46x | 16.35x | 20.16x | 11.86B | |
| 0.88% | 0.8% | 20.35x | 3.32x | 3.49x | 13.13x | 15.92x | 10.23B | |
| 3.39% | 3.77% | 17.46x | 3.23x | 3.28x | 12.15x | 14.69x | 8.57B | |
| 1.05% | 1.15% | 85.38x | 6.62x | - | - | - | 8.3B | |
| 3.11% | 3.12% | 17.1x | 1.45x | 2.21x | 8.57x | 11.18x | 7.72B | |
| 4.5% | 5.03% | 9.4x | 1.53x | 2.03x | 5.48x | 6.57x | 6.72B | |
| 0.14% | 0.16% | 32.1x | 5.55x | 3.47x | 15.77x | 16.53x | 6.34B | |
| 0.18% | 0.18% | 47.81x | 6.46x | 5.19x | 23.51x | 32.79x | 5.41B | |
| 2.28% | 2.78% | 22.4x | 3.42x | 3.62x | 17.25x | 20.98x | 4.06B | |
| 1.15% | 1.33% | 34.04x | 8.02x | 6.55x | 24.12x | 26.9x | 3.98B | |
| 2.05% | 2.34% | 10.15x | 0.58x | 1.83x | 7.62x | 9.25x | 3.27B | |
| 2.52% | 2.77% | 15.92x | 3.69x | 3.75x | 13.44x | 14.73x | 2.97B | |
| 3.18% | 3.37% | 18.9x | 5.19x | 6.03x | 17.2x | 18.29x | 2.45B | |
| Average | 1.85% | 2.02% | 27.17x | 3.94x | 3.83x | 14.70x | 17.62x | 10.77B | |
| Weighted average by Cap. | 1.48% | 1.59% | 27.96x | 3.77x | 4.12x | 15.42x | 18.84x |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition